
Opinion|Videos|April 3, 2025
Discussing ADC Risks, Benefits, and Regimens With Patients
Panelists discuss how health care professionals use clear, tailored communication to explain antibody-drug conjugate (ADC) risks, benefits, and regimens. They provide education, address concerns, and ensure adherence through counseling and shared decision-making.
Advertisement
Episodes in this series

Video content above has been prompted by the following:
- At your institution, how do you effectively communicate with patients about ADC therapies (eg, risks, benefits, treatment regimens)?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Halfway There Is Nowhere
2
CagriSema Outperforms Semaglutide in Lowering HbA1C, Reducing Weight Across REIMAGINE Trials
3
ADA 2026: Key Pharmacotherapy Advances in Type 1 and Type 2 Diabetes
4
Metformin Cuts Long COVID Risk by 50%, New Trial Confirms
5




















































































































